Summary of Presentation from the Targeted Therapy in Lung Cancer Meeting
Molecular Targeted Agents and Biologic Therapies for Lung Cancer
Targeted Therapy in Lung Cancer
Mitotic Inhibitors
Mitotic Inhibitors
HER-1, 2, and 3
Targeting FGFR, Ephrins, Mer, MET, and PDGFR-α in Non-small Cell Lung Cancer
Insulin-Like Growth Factor Receptor
Angiogenesis Inhibitors
Poly Adenosine Diphosphate-Ribose Polymerase Inhibitors and Heat Shock Protein 90 Inhibitors
Targeting the Phosphatidylinosital 3-Kinase, Akt, and Mammalian Target of Rapamycin Pathway in Non-small Cell Lung Cancer
Histone Deacetylase Inhibitors
Inhibition of MET Receptor Tyrosine Kinase and Its Ligand Hepatocyte Growth Factor
Novel Mechanisms and Targets
Summary of Presentations from the 11th Targeted Therapies for Lung Cancer Meeting
Apoptotic Pathway Manipulation
Targeting the Hedgehog and Notch Signaling Pathways
Summary of Presentations from the 11th Targeted Therapies for Lung Cancer Meeting
Mesothelioma and Small Cell Lung Cancer